Tech

October 12, 2012

NASA signs agreement to develop nasal spray for motion sickness

NASA’s Johnson Space Center in Houston and Epiomed Therapeutics Inc. of Irvine, Calif., have signed an agreement to develop and commercialize a NASA-crafted, fast-acting nasal spray to fight motion sickness.

Under the Space Act Agreement, Epiomed will formulate the drug, called intranasal scopolamine, or INSCOP. Astronauts often experience motion sickness in space. As a result, NASA has conducted extensive research into the causes and treatments for the condition. Scopolamine is effective and can be administered as a tablet or injected. With

precise dosage, the NASA spray formulation has been shown to work faster and more reliably than the oral form.

“NASA and Epiomed will work closely together on further development of INSCOP to optimize therapeutic efficiency for both acute and chronic treatment of motion sickness which can be used by NASA, the Department of Defense and world travelers on land, in the air and on the seas,” said Lakshmi Putcha, developer of the innovative treatment strategy at Johnson.

A gel formulation of INSCOP was developed and tested under a Space Act Agreement between Johnson and the Naval Aerospace Medical Research Laboratory in Pensacola, Fla. Results from that trial were published in the journal Aviation, Space and Environmental Medicine in April 2010 that suggest INSCOP is a fast-acting and reliable way to prevent and treat motion sickness.

The U.S. Navy is working on an agreement with Epiomed to test the nasal spray. NASA and Epiomed will collaborate on clinical trials related to the Federal Drug Administration requirements. NASA is transferring sponsorship of future clinical trials and FDA approvals to Epiomed, which will supply the product for use by NASA and others.

 




All of this week's top headlines to your email every Friday.


 
 

 
University of Alaska-Fairbanks photograph by Chris Larsen

NASA airborne campaigns focus on climate impacts in Arctic

University of Alaska-Fairbanks photograph by Chris Larsen Changes in more than 130 Alaskan glaciers are being surveyed by scientists at the University of Alaska-Fairbanks in a DHC-3 Otter as part of NASA’s multi-year Oper...
 
 
NASA/SSAI photograph by Edward Winstead

ACCESS II confirms jet biofuel burns cleaner

NASA/ORAU photograph by Richard Moore NASA’s DC-8 research aircraft leads one of the ACCESS II sampler aircraft across the early morning California sky.   Flying high above the California desert, NASA researchers rec...
 
 

Sparks fly as NASA pushes limits of 3-D printing technology

NASA has successfully tested the most complex rocket engine parts ever designed by the agency and printed with additive manufacturing, or 3-D printing, on a test stand at NASA’s Marshall Space Flight Center in Huntsville, Ala. NASA engineers pushed the limits of technology by designing a rocket engine injector – a highly complex part that...
 

 
NASA photograph by David Alexander

NASA MQ-9 remotely piloted aircraft completes visual, radar mission in Hawaii

NASA photograph “Ikhana,” NASA’s MQ-9 remotely piloted research aircraft, carries a maritime radar in a specialized centerline pod during a flight to check out systems prior to the aircraft’s deployment ...
 
 
NASA photograph by Tom Tschida

NASA Armstrong’s space shuttle Mate-Demate Device coming down

NASA photograph by Tom Tschida The space shuttle Mate-Demate Device that stood as an iconic symbol of NASA’s now-concluded Space Shuttle Program at NASA Armstrong Flight Research Center for 38 years is being dismantled af...
 
 

NASA awards research facilities, engineering support services contract

NASA has awarded a contract for research facilities and engineering support services to InuTeq, LLC of Greenbelt, Maryland, in support of the Mission Information and Test Systems Directorate at NASA’s Armstrong Flight Research Center, Edwards, Calif. This cost-plus-award-fee contract covers a one-year base period beginning Nov. 1, 2014 and four one-year options, and is valued...
 




0 Comments


Be the first to comment!


Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>